(PRNewsfoto/Outcomes Matter Innovations, LLC)
“As a proven navigator and leader within a very complex healthcare system, Dr. Pecora is the ultimate chief executive for OMI,” said Andrew Jennis, MD, board member, OMI. “As a world-class researcher, he understands what it takes to identify and bring forward medicines that will save lives, and as former Chief Innovation Officer in one of America’s largest and best healthcare systems, he is a proven leader in transforming patient care. We are thrilled that he will lead us forward.”
Dr. Pecora comes to OMI from Hackensack Meridian Health, where he was President, Physician Enterprise and Chief Innovation Officer. While there, he helped create and led development of the John Theurer Cancer Center and played a key role in the success of many of Hackensack Meridian strategic partnerships, including those with Memorial Sloan Kettering Cancer Center and Georgetown Lombardi Cancer Center. He has also been a champion in engaging physician leaders to innovate and transform health care delivery since 1990.
“It is absolutely critical that we innovate in the delivery and quality of patient care, in order to improve outcomes for individual patients and reduce total cost of care for populations.” said Dr. Pecora. “If our healthcare systems are not geared toward patient need, patients suffer ultimately. Working with organizations to put patients front and center in their planning and organizational efforts, instituting proven approaches to driving better care and outcomes, have been driving forces in my life and career, and I look forward to championing these efforts with healthcare clients through OMI.”
When Dr. Pecora began working with the John Theurer Center, he elevated cancer care to the department level. His accomplishments there include the recruitment of leading oncologists from around the U.S., the addition of innovative research and clinical trials, expansion of patient care services and introduction of new, state-of-the-art technology, all of which helped make John Theurer Center one of the top 50 cancer centers in the country – and the only one in New Jersey with this designation.
“Whether through partnerships with healthcare systems, engaging physicians or work with corporate boards, I’ve gained a lifetime of insights into administration, finance and effective delivery of healthcare,” continued Pecora. “What is apparent is that many regard growth of a medical institution and the provision of the highest standard of excellence in care as separate goals. They are intertwined and depend upon each other. That synthesis of goals and the paths to them presents healthcare providers with an immense opportunity for improvement and success.”
Dr. Pecora is one of the world’s experts in blood and marrow stem-cell transplantation, cellular medicine, and immunology research. He has led award-winning research funded by the National Cancer Institute and the AHEPA Research Foundation and has been involved in clinical evaluation of novel agents including cancer vaccines, replication competent viruses and targeted therapies. He has also been involved in laboratory and clinical development of engineered blood and marrow stem-cell grafts for autologous and allogeneic transplantation, as well as cell therapy for regenerative medicine.
Dr. Pecora’s award-winning research has been published in many prestigious medical journals and has been funded by organizations including the National Cancer Institute, Amgen, Merck and the AHEPA Research Foundation. He is a Professor of Medicine at University of Medicine and Dentistry of New Jersey (UMDNJ) – New Jersey Medical School, at which he earned his medical degree as well as a Professor of Medicine and Oncology at Georgetown University. He completed his residency at The New York Hospital in internal medicine and conducted his fellowship training at Memorial Sloan-Kettering Cancer Center in hematology/oncology.
Dr. Pecora’s awards and honors include America’s Top Doctors, Who’s Who in the World, the ASCO Cancer Foundation Research Award and the Gallo Award for outstanding cancer research.
About Outcomes Matter Innovations
A healthcare transformation company with multiple diversified interests in the healthcare arena, Outcomes Matter Innovations, LLC (OMI) was created by a group of physicians with a mission: providing solutions for improving patient outcomes and reducing total cost of care and removing the administrative burdens facing hospitals and independent physicians in today’s constantly changing healthcare environment. Accessing their extensive experience on the front lines of medicine, OMI has achieved great success in revenue growth and innovation while maintaining the highest standards of excellence for patients.
OMI seeks to transform the way healthcare works from each vantage point of the continuum of care, leveraging data and technology to improve outcomes and reduce cost of care. OMI specializes in emerging healthcare markets and technologies, joint ventures, development and growth of hospital systems, cancer centers, and creation of physician groups and networks at scale.
Attracting the best and brightest talent from all areas of the healthcare landscape to create and grow multiple different business under the OMI umbrella, the company’s goal is innovation that will be a model for transforming the entire healthcare industry.
For additional information, please visit www.omimanagement.com.
CONTACT: Merissa Muller, email@example.com, 212-715-1699
SOURCE Outcomes Matter Innovations, LLC